|
Immunologic Disorders
Citations 41-50 of 351 total displayed.
|
Past content
(since Jan 1998):
|
- Research Letters
Genetic Polymorphism at Codon 129 of the Prion Protein Gene Is Not Associated With Multiple Sclerosis
- Olaf Stüve; Carsten Korth; Pablo Gabatto; Elizabeth M. Cameron; Wei Hu; Todd N. Eagar; Nancy L. Monson; Elliot M. Frohman; Michael K. Racke; Cyrus P. Zabetian; Jorge R. Oksenberg
Arch Neurol 2009; 66: 280-281.
[Extract]
[Full text]
[PDF]
- Editorials
Defining Multiple Sclerosis Treatment Response With Magnetic Resonance Imaging: How Much Activity Is Too Much?
- Paul S. Giacomini; Douglas L. Arnold; Amit Bar-Or; Jack P. Antel
Arch Neurol 2009; 66: 19-20.
[Extract]
[Full text]
[PDF]
- Original Contributions
Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis: A 3-Year Monthly Imaging Study
- Annie W. Chiu; Nancy Richert; Mary Ehrmantraut; Joan Ohayon; Shiva Gupta; Giuseppe Bomboi; Deeya Gaindh; Fredric K. Cantor; Joseph A. Frank; Henry F. McFarland; Francesca Bagnato
Arch Neurol 2009; 66: 39-43.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Imaging Correlates of Leukocyte Accumulation and CXCR4/CXCL12 in Multiple Sclerosis
- Natalia M. Moll; Michael B. Cossoy; Elizabeth Fisher; Susan M. Staugaitis; Barbara H. Tucky; Anna M. Rietsch; Ansi Chang; Robert J. Fox; Bruce D. Trapp; Richard M. Ransohoff
Arch Neurol 2009; 66: 44-53.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
- Mark P. Gorman; Brian C. Healy; Mariann Polgar-Turcsanyi; Tanuja Chitnis
Arch Neurol 2009; 66: 54-59.
[Abstract]
[Full text]
[PDF]
- Observations
Continued Disease Activity in a Patient With Multiple Sclerosis After Allogeneic Hematopoietic Cell Transplantation
- Jian-Qiang Lu; Jan Storek; Luanne Metz; V. Wee Yong; Anne M. Stevens; Richard A. Nash; Jeffrey T. Joseph
Arch Neurol 2009; 66: 116-120.
[Abstract]
[Full text]
[PDF]
- Editorials
Central Nervous System Immune Surveillance: On Natalizumab, Dendritic Cells, and Dangerous Immune Privilege
- Burkhard Becher
Arch Neurol 2008; 65: 1566-1567.
[Extract]
[Full text]
[PDF]
- Original Contributions
Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- Maria del Pilar Martin; Petra D. Cravens; Ryan Winger; Elliot M. Frohman; Michael K. Racke; Todd N. Eagar; Scott S. Zamvil; Martin S. Weber; Bernhard Hemmer; Nitin J. Karandikar; B. K. Kleinschmidt-DeMasters; Olaf Stüve
Arch Neurol 2008; 65: 1596-1603.
[Abstract]
[Full text]
[PDF]
- Observations
Natalizumab Use in Pediatric Multiple Sclerosis
- Peter Huppke; Wiebke Stark; Claudia Zürcher; Brenda Huppke; Wolfgang Brück; Jutta Gärtner
Arch Neurol 2008; 65: 1655-1658.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis: A 3-Year Monthly Imaging Study
- Annie W. Chiu; Nancy Richert; Mary Ehrmantraut; Joan Ohayon; Shiva Gupta; Giuseppe Bomboi; Deeya Gaindh; Fredric K. Cantor; Joseph A. Frank; Henry F. McFarland; Francesca Bagnato
Arch Neurol 66.1.noc80047.
[Abstract]
[Full text]
[]
|
|
